The concept of prenatal gene therapy.

[1]  M. Herlyn,et al.  Placental gene transfer: transgene screening in mice for trophic effects on the placenta. , 2009, American journal of obstetrics and gynecology.

[2]  A. Flake,et al.  Prenatal stem cell transplantation and gene therapy. , 2009, Clinics in perinatology.

[3]  C. Rodeck,et al.  Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep , 2008, Gene Therapy.

[4]  Anna L David,et al.  Gene therapy for the fetus: is there a future? , 2008, Best practice & research. Clinical obstetrics & gynaecology.

[5]  C. Rodeck,et al.  Fetal gene transfer. , 2007, Current opinion in molecular therapeutics.

[6]  Y. Kaneda,et al.  Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during mid-term pregnancy lowers systemic maternal blood pressure. , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[7]  H. Volk,et al.  Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. , 2006, Journal of reproductive immunology.

[8]  D. Bianchi,et al.  Fetal therapy for single gene disorders. , 2005, Clinical obstetrics and gynecology.

[9]  C Coutelle,et al.  Gene Therapy Progress and Prospects: Fetal gene therapy – first proofs of concept – some adverse effects , 2005, Gene Therapy.

[10]  Christof von Kalle,et al.  Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  J. Prieto,et al.  In utero gene therapy: current challenges and perspectives. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Simon N. Waddington,et al.  Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice , 2005 .

[13]  Paul J Park,et al.  The Sheep Model of in utero Gene Therapy , 2003, Fetal Diagnosis and Therapy.

[14]  黄莚庭,et al.  Fetal surgery , 2003, BMJ : British Medical Journal.

[15]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[16]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[17]  C. von Kalle,et al.  Murine Leukemia Induced by Retroviral Gene Marking , 2002, Science.

[18]  M. Harrison.  Surgically correctable fetal disease. , 2000, American journal of surgery.

[19]  L. Andrews,et al.  Prenatal gene transfer: Scientific, medical, and ethical issues: A report of the recombinant DNA advisory committee , 2000 .

[20]  W. Anderson,et al.  Prospects for in utero human gene therapy. , 1999, Science.

[21]  F. Gage,et al.  Prenatal gene therapy: can the technical hurdles be overcome? , 1999, Molecular medicine today.

[22]  J. Couzin.  RAC Confronts in Utero Gene Therapy Proposals , 1998, Science.

[23]  F. Gage,et al.  Gene transfer to the rodent placenta in situ. A new strategy for delivering gene products to the fetus. , 1998, The Journal of clinical investigation.

[24]  J. Whitsett,et al.  Intraamniotic Administration of an Adenoviral Vector for Gene Transfer to Fetal Sheep and Mouse Tissues , 1995, Pediatric Research.

[25]  W. Colledge,et al.  The challenge of fetal gene therapy , 1995, Nature Medicine.

[26]  S. A. Watkins,et al.  Retrovirus-mediated gene transfer in lungs of living fetal sheep. , 1995, Gene therapy.

[27]  A. Moorman,et al.  Persistent expression of genes transferred in the fetal rat liver via retroviruses , 1995, Somatic cell and molecular genetics.

[28]  G. Koretzky,et al.  Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. , 1995, The Journal of clinical investigation.

[29]  T. Ochiya,et al.  Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice , 1995, Nature Genetics.

[30]  A. Wynshaw-Boris,et al.  Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. , 1990, The Journal of biological chemistry.

[31]  P. Kantoff,et al.  In utero gene transfer and expression: a sheep transplantation model. , 1989, Blood.

[32]  S. McCandless,et al.  The burden of genetic disease on inpatient care in a children's hospital. , 2004, American journal of human genetics.

[33]  S. Ylä-Herttuala,et al.  Fetal membranes act as a barrier for adenoviruses: gene transfer into exocoelomic cavity of rat fetuses does not affect cells in the fetus. , 2004, American journal of obstetrics and gynecology.

[34]  C. Rodeck,et al.  The current status and future directions of fetal gene therapy , 2003 .

[35]  P. Boileau,et al.  Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. , 2000, Human gene therapy.

[36]  J. Touraine.  In-utero transplantation of fetal liver stem cells into human fetuses. , 1992, Human reproduction.

[37]  P. Kantoff,et al.  Gene therapy: efforts at developing large animal models for autologous bone marrow transplant and gene transfer with retroviral vectors. , 1987, Ciba Foundation symposium.

[38]  P. Kantoff,et al.  Gene transfer and expression in nonhuman primates using retroviral vectors. , 1986, Cold Spring Harbor symposia on quantitative biology.